ELVElevance Health

Health care · Health Insurance · NYSE

Elevance Health and its direct and indirect subsidiaries, referred to throughout this document as “we,” “us,” “our,” the “Company” or “Elevance Health,” is a leading health company bringing together the concepts of elevate and advance. 10-K, Item 1

Headquarters: Indianapolis, IN
CEO: Gail Boudreaux
Next results: around Jan 27, 2027

Compare with peers → Embed

RevenueFY2016–25 $199.1B+12.5% Highest in 10 years 10-K FY2025 · XBRL Net incomeFY2016–25 $5.7B−5.3% FY2024: $6.0B 10-K FY2025 · XBRL Free cash flowFY2016–25 $3.2B−30.3% FY2024: $4.6B 10-K FY2025 · XBRL Operating marginFY2016–25 3.6%−0.8 pts 5.7% in FY2016 10-K FY2025 · XBRL

What changed

10-K filed Feb 6, 2026 against Feb 20, 2025

Area	What changed	Source
Risk factors	9 new paragraphs, nothing like them in the previous 10-K	10-K Item 1A
Accounting checks	8 other checks clear	10-K · XBRL
Insiders	No open-market buys in the last 90 days	Form 4
Filings	3 in the last 30 days	EDGAR

Each row opens the detail with the quote and the filing. A row is a change worth reading, not a verdict.

What's new, in their words

10-K filed Feb 6, 2026

Paragraphs in Risk Factors that were not in the 10-K filed 2025-02-20. Quoted as filed.

Revenues from the Medicare and Medicaid programs are determined, in whole or in part, by the federal government and/or applicable state governments, and base premium rates paid by each state or federal agency differ depending upon a combination of factors such as defined upper payment limits, a member’s health status, age, gender,…
10-K, Item 1A

All 9 new paragraphs →

Accounting checks

latest 10-K

8 of 8 clear 0 worth a look. Checks, not verdicts.

✓
Same auditor in both 10-Ks: Ernst & Young LLP
✓
No statement of substantial doubt about going concern
✓
No 8-K item 4.02 in the last 2 years
✓
No NT 10-K or NT 10-Q in the last 2 years
✓
The same matters as last year: Valuation of Incurred but Not Paid Claims
✓
No sentence in the 10-K concludes that controls were not effective because of a material weakness
✓
No 8-K item 2.06 in the last 2 years
✓
No 8-K item 1.03 in the last 2 years

How each check works, with sources →

In the last 30 days

All filings →

Oct 28, 2026Offering Shelf registration: shares and other securities, amount not fixed S-3ASR · We may offer and sell, from time to time, one or any combination of the securities we describe in this prospectus.
Oct 21, 20268-K Quarterly results 8-K item 2.02
Oct 21, 202610-Q Quarterly report (10-Q) period ended Sep 30, 2026

Get an email when this changes: new risk paragraphs, accounting items, insider purchases, a new 10-K or 10-Q. RSS feed

Work on ELV in a spreadsheet: Excel workbook (a sheet per section, ten years by column, charts, links to the filings) · CSV. For a Google Sheet that stays up to date, paste =IMPORTDATA("https://tickdelta.com/company/ELV/export.csv") into a cell.